Close-up digital illustration of a DNA double helix with colorful molecular structures.

Biomarkers for action

We unlock the promise of precision medicine by providing comprehensive information of how cells respond to DNA damage in preclinical and clinical samples, helping pharmaceutical companies develop better treatments and helping doctors match the right patient to the best treatment.

A Francis Crick Institute spinout

Our vision is simple yet profound: every cancer patient examined, diagnosed, and treated according to the real-time functional behaviour of their tumour—making personalised medicine not just a goal, but a measurable reality.

Let’s Stay in Touch

Join our journey.

Our Expertise

Anaid Benitez, founder of STRATISAL and Translation Scholar at The Francis Crick Institute

Expert scientists in the DNA damage response (DDR) with the right academic, industry, and commercial experience to integrate our technology into your development and decision-making pipeline.

Founder and CEO

Anaid Benitez PhD

Miroslav Ivanov
Chief Scientific Officer

Miroslav Ivanov PhD

A young man with glasses and a beard, wearing a navy DKNY t-shirt, stands with his arms crossed and smiling in a modern building with multiple levels in the background.
Senior Scientist

Marek Adamowicz PhD

Scientific Advisory Board

Smiling senior man with a white beard and bald head, wearing a maroon zip-up sweater, outdoors with a blue background.
Group Leader at The Crick

Stephen C. West PhD

Abstract wooden sculpture with a sphere balanced on a curved piece, placed on a black cube, against a neutral background.
Pending Employer Approval

Big Pharma Exec